| Literature DB >> 33579632 |
Beverley C Millar1, John E Moore2.
Abstract
Entities:
Keywords: COVID-19; Disinfection; Heat inactivation; Norovirus; SARS CoV-2; Thermal inactivation
Year: 2021 PMID: 33579632 PMCID: PMC7843083 DOI: 10.1016/j.idh.2021.01.001
Source DB: PubMed Journal: Infect Dis Health ISSN: 2468-0451
Thermal performance of steam disinfector using the Ao Concept according to EN ISO 15883. Reprinted from [1] with permission from Elsevier.
| Probe position | Maximum temperature reached (oC) | Time (sec) at (A0 equivalent) | |||
|---|---|---|---|---|---|
| ≥70 °C | ≥80 °C | ≥90 °C | ≥93 °C | ||
| 1 | 100.0 | 800 (Ao = 60) | 600 (Ao = 600) | 400 (Ao = 3000) | 340 (Ao = 6000) |
| 2 | 100.1 | 820 (Ao = 60) | 620 (Ao = 600) | 400 (Ao = 3000) | 320 (Ao = 6000) |
| 3 | 100.5 | 800 (Ao = 60) | 580 (Ao = 60) | 400 (Ao = 3000) | 320 (Ao = 6000) |
| 4 | 99.9 | 780 (Ao = 60) | 580 (Ao = 60) | 400 (Ao = 3000) | 340 (Ao = 6000) |
| 5 | 100.1 | 800 (Ao = 60) | 600 (Ao = 600) | 420 (Ao = 3000) | 340 (Ao = 6000) |
| 1 | 98.0 | 516 (Ao = 6) | 400 (Ao = 60) | 280 (Ao = 600) | 200 (Ao = 3000) |
| 2 | 98.4 | 520 (Ao = 6) | 400 (Ao = 60) | 280 (Ao = 600) | 220 (Ao = 3000) |
| 3 | 99.0 | 500 (Ao = 6) | 400 (Ao = 60) | 280 (Ao = 600) | 240 (Ao = 3000) |
| 4 | 98.1 | 500 (Ao = 6) | 400 (Ao = 60) | 280 (Ao = 600) | 200 (Ao = 3000) |
| 5 | 98.5 | 520 (Ao = 6) | 420 (Ao = 60) | 300 (Ao = 600) | 220 (Ao = 3000) |
| 1 | 95.7 | 510 (Ao = 6) | 300 (A0 = 60) | 120 (A0 = 600) | 60 (A0 = 600) |
| 2 | 96.7 | 510 (Ao = 6) | 330 (A0 = 60) | 120 (A0 = 600) | 60 (A0 = 600) |
| 3 | 96.7 | 510 (Ao = 6) | 330 (A0 = 60) | 150 (A0 = 600) | 90 (A0 = 600) |
| 4 | 95.3 | 480 (Ao = 6) | 270 (A0 = 60) | 90 (A0 = 600) | 30 (A0 = 600) |
| 5 | 96.7 | 510 (Ao = 6) | 300 (A0 = 60) | 120 (A0 = 600) | 60 (A0 = 600) |
| 6 | 89.9 | 460 (A0 = 6) | 320 (A0 = 60) | 0 | 0 |
| 7 | 88.8 | 360 (A0 = 6) | 200 (A0 = 60) | 0 | 0 |
| 8 | 86.1 | 360 (A0 = 6) | 180 (A0 = 60) | 0 | 0 |
| 9 | 93.0 | 480 (A0 = 6) | 400 (A0 = 60) | 160 (A0 = 600) | 1 |
| 10 | 89.6 | 480 (A0 = 6) | 240 (A0 = 60) | 0 | 0 |
| 6 | 89.3 | 180 (A0 = 6) | 60 (A0 = 60) | 0 | 0 |
| 7 | 88.0 | 260 (A0 = 6) | 160 (A0 = 60) | 0 | 0 |
| 8 | 83.5 | 320 (A0 = 6) | 180 (A0 = 60) | 0 | 0 |
| 9 | 90.0 | 260 (A0 = 6) | 140 (A0 = 60) | 0 | 0 |
| 10 | 89.0 | 380 (A0 = 6) | 260 (A0 = 60) | 0 | 0 |
| 6 | 95.2 | 560 (A0 = 6) | 380 (A0 = 60) | 220 (A0 = 600) | 100 (A0 = 600) |
| 7 | 96.5 | 660 (A0 = 60) | 480 (A0 = 60) | 220 (A0 = 600) | 160 (A0 = 600) |
| 8 | 95.0 | 640 (A0 = 60) | 400 (A0 = 60) | 161 (A0 = 600) | 79 (A0 = 600) |
| 9 | 95.3 | 620 (A0 = 60) | 421 (A0 = 60) | 200 (A0 = 600) | 141 (A0 = 600) |
| 10 | 97.1 | 719 (A0 = 60) | 559 (A0 = 60) | 320 (A0 = 3000) | 241 (A0 = 3000) |
Thermal susceptibility of SARS CoV-2, norovirus and other viruses.
| Virus | Sample | Treatment | Temp. (oC) | Time (min) | Viral Titre Before Heat | Log10 reduction (LRF) |
|---|---|---|---|---|---|---|
| SARS-CoV-2 | ||||||
| SARS-CoV-2 England [ | Tissue culture fluid | Heat block | 56 | 15 | 5.8 log10 pfu/ml | 2.7 |
| 56 | 30 | 5.8 log10 pfu/ml | 4.9 | |||
| 56 | 60 | 5.8 log10 pfu/ml | 2.1 | |||
| 80 | 15 | 5.7 log10 pfu/ml | 3.5 | |||
| 80 | 30 | 5.7 log10 pfu/ml | 4.4 | |||
| 80 | 30 | 5.6 log10 pfu/ml | 4.1 | |||
| 80 | 60 | 5.6 log10 pfu/ml | ≥5.1 | |||
| 80 | 90 | 5.6 log10 pfu/ml | ≥5.1 | |||
| 95 | 1 | 5.7 log10 pfu/ml | ≥5.2 | |||
| 95 | 5 | 5.7 log10 pfu/ml | ≥5.2 | |||
| SKU:026V-03883 (Berlin, Germany) [ | Cell culture supernatant | Heat block | 56 | 30 | 3.3 × 106 | >5 |
| 60 | 60 | 3.3 × 106 | >5 | |||
| 92 | 15 | 3.3 × 106 | >6 | |||
| SKU:026V-03883 (Berlin, Germany) [ | Nasopharyngeal swab | Heat block | 60 | 60 | 3.5 × 105 | >5 |
| 56 | 30 | 3.5 × 105 | >5 | |||
| SKU:026V-03883 (Berlin, Germany) [ | Blood sera | Heat block | 56 | 30 | 3.5 × 105 | >5 |
| 60 | 60 | 3.5 × 105 | >5 | |||
| SARS-CoV-2/human/Liverpool/REMRQ0001/2020 [ | NK | NK | 80 | 60 | 1.1 × 107 | None detected |
| NK [ | N95 Respirators | Dry heat | 70 | 60 | 7.8 log | None detected |
| SARS-CoV-2, strain USA_WA1/2020 [ | Virus stock | Heating block | 100 | 5 | 6.0 log | None detected |
| Virus stock | Heating block | 56 | 45 | 6.0 log | None detected | |
| SARS CoV-2 (France) [ | Cell culture supernatant | Water Bath | 56 | 15 | 6.6 log | 3.37 |
| 56 | 30 | 6.6 log | None detected | |||
| 65 | 15 | 6.6 log | None detected | |||
| Nasopharyngeal sample | Water bath | 65 | 5 | 6.57 log | 1.74 | |
| 65 | 10 | 6.57 log | None detected | |||
| 95 | 0.5 | 6.57 log | 0.34 | |||
| 95 | 3 | 6.57 log | None detected | |||
| Sera | Water bath | 56 | 5 | 6.2 log | 1.33 | |
| 56 | 10 | 6.2 log | 3.63 | |||
| 56 | 15 | 6.2 log | None detected | |||
| SARS-CoV-2 isolates (designated hCoV-19/Cambodia/1775/2020, 1775; hCoV-19/Cambodia/2018/2020, 2018; and, hCoV-19/Cambodia/2310/2020, 2310) [ | Virus culture | Thermo-block | 56 | 30 | 4-5 log | None detected |
| 56 | 60 | 4-5 log | None detected | |||
| 98 | 2 | 4-5 log | None detected | |||
| Norovirus | ||||||
| Norovirus (GI & GII) [ | Cow's milk | 85 | 1 | 8 log10 | 6.6 ± 0.2 log10 | |
| 85 | 2 | 8 log10 | 8 log10 | |||
| 90 | 90s | 8 log10 | 8 log10 | |||
| 95 | 60s | 8 log10 | 8 log10 | |||
| 100.5 | 40s | 8 log10 | 8 log10 | |||
| Human Norovirus surrogates | ||||||
| Murine norovirus [ | PBS | Water bath | 56 | 10 | 105 PFU/ml | None detected |
| Tulane virus [ | PBS | Water bath | 56 | 30 | 105 PFU/ml | None detected |
| Aichi virus [ | PBS | Water bath | 56 | 10 | 105 PFU/ml | None detected |
| Tulane virus [ | PBS | Water bath | 56 | 30 | 105 PFU/ml | None detected |
| 63 | 10 | 105 PFU/ml | None detected | |||
| 72 | 5 | 105 PFU/ml | None detected | |||
| Murine norovirus [ | Modified Eagle's medium + PBS | Water bath | 85 | 1 | 6 × 106 PFU/ml | None detected |
| Tulane virus [ | M199-Earle's medium | Heating block | 56 | 30 | 4 × 104 -6.4 × 105 l | None detected |
| 63 | 5 | None detected | ||||
| Poliovirus Sabin 1 [ | Viral culture in stool suspension | Water bath | 73 | 3 | >4 log | Complete inactivation |